A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. [electronic resource]
Producer: 20121207Description: 1554-62 p. digitalISSN:- 1572-0241
- Acute Disease
- Adult
- Celiac Disease -- prevention & control
- Double-Blind Method
- Female
- Gastrointestinal Agents -- therapeutic use
- Glutens -- administration & dosage
- Humans
- Male
- Middle Aged
- Oligopeptides -- therapeutic use
- Secondary Prevention -- methods
- Severity of Illness Index
- Tight Junctions -- drug effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.